Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DEXLANSOPRAZOLE Cause Lung opacity? 134 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 134 reports of Lung opacity have been filed in association with DEXLANSOPRAZOLE (Dexlansoprazole). This represents 0.6% of all adverse event reports for DEXLANSOPRAZOLE.

134
Reports of Lung opacity with DEXLANSOPRAZOLE
0.6%
of all DEXLANSOPRAZOLE reports
21
Deaths
134
Hospitalizations

How Dangerous Is Lung opacity From DEXLANSOPRAZOLE?

Of the 134 reports, 21 (15.7%) resulted in death, 134 (100.0%) required hospitalization, and 34 (25.4%) were considered life-threatening.

Is Lung opacity Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DEXLANSOPRAZOLE. However, 134 reports have been filed with the FAERS database.

What Other Side Effects Does DEXLANSOPRAZOLE Cause?

Chronic kidney disease (15,973) Acute kidney injury (7,599) Renal failure (6,618) End stage renal disease (4,800) Renal injury (4,320) Tubulointerstitial nephritis (2,177) Death (1,417) Rebound acid hypersecretion (1,160) Gastrooesophageal reflux disease (1,013) Drug ineffective (859)

What Other Drugs Cause Lung opacity?

ALBUTEROL (296) PREDNISONE (216) TIOTROPIUM (196) LANSOPRAZOLE (166) IPRATROPIUM (157) ACETAMINOPHEN (153) MEPOLIZUMAB (149) PANTOPRAZOLE (140) BUDESONIDE\FORMOTEROL (139) MONTELUKAST (137)

Which DEXLANSOPRAZOLE Alternatives Have Lower Lung opacity Risk?

DEXLANSOPRAZOLE vs DEXMEDETOMIDINE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXMETHYLPHENIDATE\SERDEXMETHYLPHENIDATE DEXLANSOPRAZOLE vs DEXPANTHENOL DEXLANSOPRAZOLE vs DEXRAZOXANE

Related Pages

DEXLANSOPRAZOLE Full Profile All Lung opacity Reports All Drugs Causing Lung opacity DEXLANSOPRAZOLE Demographics